Sandu Pharmaceuticals Ltd
Sandu Pharmaceuticals Ltd Share Price Today: Live Updates & Key Insights
Get insights on Sandu Pharmaceuticals Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.
Sandu Pharmaceuticals Ltd Share Price Chart
SANDUPHARMA at 10 Jul 2026 05:25 PM Pharmaceuticals
41.00 +0.43(+1.06%)
Lowest Today 40.67
Highest Today 41.47
Today's Open 41.02
Prev. Close 40.57
52 Week High 58.80
52 Week Low 30.00
Sandu Pharmaceuticals Ltd Fundamentals
Traded Volume: 1,191
Market Cap(Cr): 39.61
Avg Traded Price 40.98
1 Year return -18.57%
Upper Circuit 41.5
Lower Circuit 40.7
P/E TTM 0.00
P/B Ratio 0.00
Traded Value(Cr) 0.49
EPS TTM NaN
Book value/Share NaN
Dividend Yield 1Y 0.00%
Sandu Pharmaceuticals Ltd Share Price Performance
Shows the percentage change in stock price over different time periods
This section highlights Sandu Pharmaceuticals Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Sandu Pharmaceuticals Ltd share price history, short-term movements, long-term trends, and overall investor sentiment
1W 0.00%
1M 0.00%
3M 0.00%
1Y -18.57%
YTD 0.00%
Sandu Pharmaceuticals Ltd Traded Volume Movement
Shows the trading volume over different time periods
This section highlights Sandu Pharmaceuticals Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment
Yesterday N/A
Day Before Yesterday N/A
1W Avg N/A
1M Avg N/A
3M Avg N/A
Sandu Pharmaceuticals Ltd Technical Details
Sandu Pharmaceuticals Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.
Support 1 40
Support 2 40
Support 3 39
Pivot Point : 41
Resistance 1 41
Resistance 2 42
Resistance 3 42
Sandu Pharmaceuticals Ltd Corporate Actions
Sandu Pharmaceuticals Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Sandu Pharmaceuticals Ltd’s capital allocation strategies.
All
Ex-Date 18-Sep-2025 Type D Description 0.80/share@8.00% Record Date 18-Sep-2025 Ratio 8.00
Ex-Date 19-Sep-2024 Type D Description 0.80/share@8.00% Record Date - Ratio 8.00
Ex-Date 18-Sep-2023 Type D Description 0.75/share@7.50% Record Date 19-Sep-2023 Ratio 7.50
Ex-Date 23-Sep-2022 Type D Description 0.75/share@7.50% Record Date 23-Sep-2022 Ratio 7.50
Ex-Date 22-Sep-2021 Type D Description 0.50/share@5.00% Record Date - Ratio 5.00
Dividends
Announcement Date 18-Sep-2025 Ex Dividend Date 18-Sep-2025 Dividend(%) 8
Announcement Date 19-Sep-2024 Ex Dividend Date 19-Sep-2024 Dividend(%) 8
Announcement Date 18-Sep-2023 Ex Dividend Date 18-Sep-2023 Dividend(%) 8
Announcement Date 23-Sep-2022 Ex Dividend Date 23-Sep-2022 Dividend(%) 8
Announcement Date 22-Sep-2021 Ex Dividend Date 22-Sep-2021 Dividend(%) 5
Bonus
No Bonus has been declared by SANDUPHARMA
Splits
No Split has been declared by SANDUPHARMA
Others
Rights No Rights has been declared by SANDUPHARMA
Sandu Pharmaceuticals Ltd Peer Comparison
Shows key financial metrics for the company and its peers
This section compares Sandu Pharmaceuticals Ltd with leading peers in the pharmaceuticals & biotechnology sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Sandu Pharmaceuticals Ltd's relative performance and valuation against major competitors.
Stock Name Mangalam Drugs and Organics Ltd ₹27.75 (+1.80%) M. Cap (Cr) 0.44 1 Yr Return (%) -69.69% P/E (TTM) -0.99 PB Ratio 0.43
Stock Name ANG Lifesciences India Ltd ₹33.25 (-4.56%) M. Cap (Cr) 0.43 1 Yr Return (%) -1.95% P/E (TTM) -3.92 PB Ratio 0.82
Stock Name Rajnish Wellness Ltd ₹0.41 (0.00%) M. Cap (Cr) 0.42 1 Yr Return (%) -55.43% P/E (TTM) -7.81 PB Ratio 0.41
Stock Name Sandu Pharmaceuticals Ltd ₹41.00 (+1.06%) M. Cap (Cr) 0.40 1 Yr Return (%) -18.57% P/E (TTM) 16.32 PB Ratio 0.91
Stock Name Goldline Pharmaceutical Ltd ₹41.10 (+0.24%) M. Cap (Cr) 0.39 1 Yr Return (%) NaN% P/E (TTM) 9.58 PB Ratio 2.98
Stock Name Roopa Industries Ltd ₹46.57 (-2.76%) M. Cap (Cr) 0.37 1 Yr Return (%) -23.78% P/E (TTM) 440.80 PB Ratio 2.08
Stock Name Lasa Supergenerics Ltd ₹7.53 (+1.35%) M. Cap (Cr) 0.38 1 Yr Return (%) -40.57% P/E (TTM) -1.11 PB Ratio 0.76
Sandu Pharmaceuticals Ltd Cash Flow
Cash flow data provides a view of how money is generated and spent by Sandu Pharmaceuticals Ltd, across its operating activities, investing activities, and financing activities.
PARTICULARS Operating Activities Mar 2026 6.12 Mar 2025 0.95 Mar 2024 0.76 Mar 2023 0.22 Mar 2022 0.95
PARTICULARS Investing Activities Mar 2026 -0.57 Mar 2025 -0.18 Mar 2024 -1.31 Mar 2023 0.53 Mar 2022 -5.47
PARTICULARS Financing Activities Mar 2026 -0.94 Mar 2025 -0.46 Mar 2024 -0.72 Mar 2023 0.58 Mar 2022 0.93
PARTICULARS Net Cash Flow Mar 2026 4.60 Mar 2025 0.31 Mar 2024 -1.27 Mar 2023 1.33 Mar 2022 -3.59
Sandu Pharmaceuticals Ltd Shareholding Pattern
This shows the ownership breakdown of Sandu Pharmaceuticals Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.
Promoter N/A%
Public N/A%
Other Institutions N/A%
FII N/A%
Mutual Funds N/A%
About Sandu Pharmaceuticals Ltd
Sandu Pharmaceuticals Limited (SPL) was established in 1987. The Company is mainly engaged in the business of manufacturing and trading of Ayurvedic medicines under the brand name 'SANDU' and is having a plant unit in Goa. SPL came out with a public issue of 17.70 lac equity shares at par, aggregating Rs 1.77 cr, in Sep.'94, to part-finance its new project in Goa costing Rs 7.28 cr to manufacture ayurvedic medicines and formulations. This plant employs the latest material handling systems and other modern machinery and has the most hygienic production facilities to attain the highest possible quality standards. Ayurvedic products have a very good market in India and abroad due to their minimal side effects.The company commenced commercial production of Ayurvedic Medicines & Formulations, at the Goa plant in 1996-97. Thereafter, it commenced production of manufacturing Unit II in Goa from May, 2002.Company manufactures quality Ayurvedic products and has acquired a unique position and reputation as a leading enterprise in the field of Ayurved. During the year 2023, it opened several sales outlets & started selling goods directly to distributors & stockiest.
Chairman & Independent Directo
Balaram Vishwanathan
Registered office Plot No 25/26/29 & 30, Pilerne Indl Estate Marra Bard, Bardez, Goa, 403511
FAX :
Background
Incorporation Year 1985
Face Value ₹10.00
Market Lot 1
FAQs on Sandu Pharmaceuticals Ltd
How to buy Sandu Pharmaceuticals Ltd shares?
To buy Sandu Pharmaceuticals Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified.
What is the market cap of Sandu Pharmaceuticals Ltd?
The company has a market capitalization of ₹39.61.
What is the PE & PB ratio of Sandu Pharmaceuticals Ltd?
PE is N/A and PB is N/A.
What is the Sandu Pharmaceuticals Ltd dividend for 2025–26?
For the 2025–26 financial year, Sandu Pharmaceuticals Ltd declared a final dividend of null% per share.